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Abstract. 
 
Proteins of the Rho family regulate cytoskel-
etal rearrangements in response to receptor stimulation 
and are involved in the establishment and maintenance 
of epithelial cell morphology. We recently showed that 
Rac is able to downregulate Rho activity and that the 
reciprocal balance between Rac and Rho activity is a 
major determinant of cellular morphology and motility 
in NIH3T3 ﬁbroblasts. Using biochemical pull-down as-
says, we analyzed the effect of transient and sustained 
oncogenic Ras signaling on the activation state of Rac 
and Rho in epithelial MDCK cells. In contrast to the ac-
tivation of Rac by growth factor-induced Ras signaling, 
we found that sustained signaling by oncogenic RasV12 
permanently downregulates Rac activity, which leads to 
upregulation of Rho activity and epithelial–mesenchy-
mal transition. Oncogenic Ras decreases Rac activity 
through sustained Raf/MAP kinase signaling, which 
causes transcriptional downregulation of Tiam1, an ac-
tivator of Rac in epithelial cells. Reconstitution of Rac 
activity by expression of Tiam1 or RacV12 leads to 
downregulation of Rho activity and restores an epithe-
lial phenotype in mesenchymal RasV12- or RafCAAX-
transformed cells. The present data reveal a novel 
mechanism by which oncogenic Ras is able to interfere 
with the balance between Rac and Rho activity to 
achieve morphological transformation of epithelial 
cells.
Key words: Ras signaling • Rho-like GTPases •
Madin-Darby canine kidney cells • RaF/MAP kinase • 
Tiam1
 
Introduction
 
Transitions between epithelial and mesenchymal pheno-
types of cells are required for morphogenetic processes
and tissue remodeling during embryogenesis. These phe-
notypic conversions are regulated by cadherin-mediated
cell–cell adhesion, growth factors, and extracellular matrix
components (for recent reviews, see Adams and Nelson,
1998; Vleminckx and Kemler, 1999). In addition, sustained
signaling by oncogenic Ras may result in morphological
transformation to a mesenchymal phenotype, which is as-
sociated with changes in gene expression, loss of E-cad-
herin-mediated cell–cell adhesions, and increased inva-
siveness of tumor cells (Behrens et al., 1989; Vleminckx et
al., 1991). Rho-family proteins, in particular Rac and Rho,
mediate distinct cytoskeletal rearrangements in response
to receptor stimulation (Hall, 1998), and have been impli-
cated in the establishment and maintenance of cadherin-
based cell–cell adhesions (Braga et al., 1997; Hordijk et al.,
1997; Takaishi et al., 1997; Kuroda et al., 1998), as well as
in the migration of epithelial cells (Keely et al., 1997; Shaw
et al., 1997; Sander et al., 1998). We recently found that
Rac is able to downregulate Rho activity and that the bal-
ance between Rac and Rho activity determines the cellular
morphology and motile behavior of NIH3T3 fibroblasts
(Sander et al., 1999). The mechanism by which oncogenic
Ras induces morphological transformation of epithelial
cells is still poorly understood. Here, we used biochemical
pull-down assays to analyze the activation state of Rac
and Rho in response to Ras signaling in epithelial MDCK
cells. Our data indicate that, in contrast to growth factor-
induced Ras signaling, oncogenic Ras downregulates Rac
and upregulates Rho activity, leading to epithelial–mesen-
chymal transition. Oncogenic Ras-mediated downregula-
tion of Rac activity is caused by sustained activation of the
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Raf/MAP kinase pathway, which results in transcriptional
downregulation of the Rac-specific exchange factor, Tiam1
(Habets et al., 1994; Michiels et al., 1995). Reconstitution
of Rac activity in mesenchymal MDCK cells transformed
by activated mutants of Ras or Raf, downregulates Rho
activity and restores the epithelial phenotype. Our data
suggest that oncogenic Ras is able to induce a mesenchy-
mal phenotype in epithelial MDCK cells by influencing
the balance between the activation state of Rac and Rho
proteins.
 
Materials and Methods
 
Cells and Retroviral Transductions
 
MDCK cells, MDCKf3 cells expressing RasV12, and derivatives thereof
were grown in DME supplemented with 10% FCS and antibiotics. The
retroviral vector encoding C1199Tiam1 and transduced MDCK cells, and
RasV12-transformed MDCKf3 cells have been described (Hordijk et al.,
1997). Constitutively active, myc-tagged RafCAAX and p110CAAX
cDNAs were cloned into a modified retroviral LZRS vector (Kinsella and
Nolan, 1996; Michiels et al., 2000) and stable cell lines were generated by
retroviral transduction and selection for neomycin resistance as described
(Sander et al., 1999). MDCK-RafCAAX cells expressing Tiam1 were gen-
erated by superinfection with retrovirus encoding C1199Tiam1 and a zeo-
cin-resistance marker and selected in medium containing G418 and zeocin
(Cayla). For Rac and Rho activity assays, cells were stimulated with 10 ng/
ml recombinant hepatocyte growth factor (HGF)
 
1
 
 for the indicated times.
Where indicated, cells were pretreated for 4 h with 20 
 
m
 
M of the phos-
phatidylinositol 3 (PI3) kinase inhibitor, LY294002 (Calbiochem).
 
Rac and Rho Activity Assays
 
Rac and Rho activity assays were performed as previously described
(Sander et al., 1998, 1999; Reid et al., 1999). In brief, 10
 
7
 
 cells were grown
in 10-cm dishes, washed in cold phosphate buffered saline, and lysed on
ice in lysis buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 100 mM NaCl,
10% glycerol, 5 mM MgCl
 
2
 
, and protease inhibitors). Cleared lysates were
incubated for 30 min at 4
 
8
 
C with glutathione S transferase (GST)-PAK or
GST-rhotekin (Sander et al., 1998, 1999; Reid et al., 1999; Ren et al., 1999)
precoupled to glutathione-Sepharose beads (Amersham Pharmacia Bio-
tech) to precipitate GTP-bound Rac and Rho, respectively. Precipitated
complexes were washed three times in lysis buffer and boiled in sample
buffer. Total lysates and precipitates were analyzed on Western blot using
mAbs against Rac1 (Transduction Laboratories) and RhoA (Santa Cruz
Biotechnology, Inc.).
 
Protein and RNA Analysis
 
Activated, phosphorylated forms of MAPK and PKB/Akt were detected
using antibodies from New England Biolabs, Inc. Anti-MAPK antibody
was provided by P. Hordijk (CLB, Amsterdam, The Netherlands), and
anti-Akt1 antibody was obtained from Santa Cruz Biotechnology, Inc.
Tiam1 protein levels were analyzed by immunoprecipitation using anti-
Tiam1 (C16) polyclonal antibody from Santa Cruz Biotechnology, Inc.,
followed by Western blotting with anti-Tiam1 antibody 
 
a
 
DH (Habets et
al., 1994). RafCAAX was detected with the myc-tag–specific antibody,
9E10. RNA analysis was performed using standard procedures (Habets et
al., 1994).
 
Immunofluorescence
 
For immunofluorescence, wild-type MDCK and transduced cell popula-
tions were stained with primary antibody recognizing 
 
b
 
-catenin (Trans-
duction Laboratories) and rhodamine-conjugated phalloidin (Molecular
Probes, Inc.) to stain for F-actin. Images were collected by confocal mi-
croscopy (Leica).
 
Results
 
HGF-induced Ras Activation Increases Rac and Rho 
Activity through Independent Signaling Pathways
 
Growth factors like HGF and PDGF have been shown to
activate Rac through Ras-dependent PI3 kinase signaling.
Dominant negative RasN17 was demonstrated to inhibit
HGF- or PDGF-induced membrane ruffling, whereas ac-
tive RasV12 induces membrane ruffling in a PI3 kinase-
dependent manner (Ridley et al., 1995; Rodriguez-Viciana
et al., 1997; Scita et al., 1999). Consistent with this signal-
ing model, HGF/cMet receptor stimulation of MDCK cells
resulted in a rapid and transient increase in Rac activity
that returned to basal levels within ten minutes and was in-
hibited by pretreatment of cells with the PI3 kinase inhibi-
tor, LY294002 (Fig. 1 a). These findings do not exclude
that a possible direct activation of PI3 kinase by HGF/
cMet receptor signaling may also contribute to Rac activa-
tion. The activation of Rac coincided with the induction of
membrane ruffles, but preceded HGF-induced cell scatter-
ing by a few hours (data not shown). HGF also stimulated
activation of Rho, which was much more prolonged than
the activation of Rac (Fig. 1 a). Increased Rho activity was
still observed four hours after stimulation, and may be re-
quired for the HGF-induced scatter response of MDCK
cells. Rho activation was not dependent on PI3 kinase ac-
tivity (Fig. 1 a), indicating that HGF/cMet receptor stimu-
lation activates Rac and Rho through independent signal-
ing pathways.
 
Oncogenic Ras Signaling Downregulates Rac Activity 
and Upregulates Rho Activity
 
In contrast to the activation of Rac by HGF, we found that
sustained Ras signaling in subclones and populations of
RasV12-transformed MDCK cells resulted in a permanent
downregulation of Rac activity (Fig. 1 b). Others have
shown that microinjection of RasV12 in different cell
 
1
 
Abbreviations used in this paper:
 
 GST, glutathione S transferase; HGF,
hepatocyte growth factor; PI3, phosphatidylinositol 3.
Figure 1. Differential regula-
tion of Rac and Rho activity
by transient and sustained
Ras signaling. a, Rac1 and
RhoA activity was analyzed
in MDCK cells stimulated for
the indicated times with 10
ng/ml HGF. Right, cells were
pretreated with the PI3 ki-
nase inhibitor LY294002 as
indicated. b and c, Rac and
Rho activities in wild-type
MDCK cells or in MDCK
cells stably expressing acti-
vated mutants of Ras (b) or
Raf kinase (c). 
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types is followed by membrane ruffling and lamellipodia
formation, indicative of Rac activation (Bar-Sagi and Fera-
misco, 1986; Ridley et al., 1992; Rodriguez-Viciana et al.,
1997; Scita et al., 1999). However, these experiments re-
flect short-term effects of Ras signaling, consistent with
the observed stimulation of Rac activity by HGF (Fig. 1 a).
Downregulation of Rac activity in RasV12-transformed
cells is accompanied by increased Rho activity (Fig. 1 b)
and epithelial–mesenchymal transition (Fig. 2 a). Upregu-
lation of Rho activity alone by expression of activated
RhoV14 in MDCK cells is not sufficient to induce transi-
tion to a mesenchymal phenotype (data not shown), indi-
cating that the downregulation of Rac represents a crucial
step in Ras-induced morphological cell transformation.
Epithelial cells expressing RasV12 have lost E-cadherin–
mediated cell–cell adhesions and exhibit a fibroblast-like
and highly migratory phenotype (Fig. 2 a). Considering
the roles for Rac in cell spreading (van Leeuwen et al.,
1997; D’Souza-Schorey et al., 1998) and Rho in cell con-
traction (Zhong et al., 1997), the mesenchymal phenotype
of RasV12-transformed MDCK cells is consistent with the
low Rac and high Rho activities, as observed in these cells.
Immunostaining with vinculin-specific antibodies and rho-
damine-labeled phalloidin revealed a characteristic Rho-
induced pattern of pronounced focal contacts at the end of
thick stress fibers in the fibroblastoid RasV12-transformed
cells (not shown). In contrast, in epithelial, Tiam1-express-
ing RasV12-transformed MDCK cells, which exhibit high
Rac and low Rho activity, we found adhesion complexes at
the cell periphery (presumably Rac-mediated), as well as
small focal contacts throughout the basal side of the cell at
the end of short thin stress fibers. Previously, we have ob-
served a similar difference in distribution of adhesion
complexes and stress fibers in fibroblastoid versus epithe-
lial-like NIH3T3 cells, which show opposing levels of Rac
and Rho activities (Sander et al., 1999).
 
Oncogenic Ras Induces Morphological Transformation 
of MDCK Cells through Sustained Raf/MAP
Kinase Signaling
 
To investigate the signaling pathways activated by sus-
tained Ras signaling that lead to phenotypic changes and
downregulation of Rac activity, we introduced activated
forms of the Ras effectors Raf kinase (RafCAAX) and
PI3 kinase (p110CAAX) into epithelial MDCK cells by
retroviral transduction. Activation of both effector path-
ways in transduced cell populations was examined using
antibodies directed against phosphorylated MAP kinase
and PKB/Akt, two downstream components of Raf and
PI3 kinase signaling, respectively (Marshall, 1996). As ex-
pected, both the MAP kinase and the PKB/AKT pathways
were activated in RasV12-transformed cells, whereas Raf-
CAAX or p110CAAX expression resulted in specific acti-
vation of their downstream targets (Fig. 2 b). In contrast to
sustained PI3 kinase signaling, constitutive activation of
the Raf/MAP kinase pathway by RafCAAX was sufficient
to induce transition to a mesenchymal phenotype (Fig. 2
a). Similar to oncogenic RasV12 (Fig. 1 b), sustained Raf
signaling (Fig. 1 c), but not PI3 kinase signaling (not
shown) resulted in decreased Rac and increased Rho ac-
tivity. We thus conclude that oncogenic Ras regulates Rac
and Rho activities through sustained activation of the Raf/
MAP kinase pathway.
 
Sustained Raf/MAP Kinase Signaling Results in 
Transcriptional Downregulation of the Rac-specific 
Exchange Factor, Tiam1
 
MAP kinase controls cellular behavior by regulating the
transcription of a large number of genes. Therefore, we
examined whether downregulation of Rac activity was
caused by altered expression of Rac-specific exchange fac-
tors, like Tiam1, that is endogenously expressed in MDCK
cells (Michiels et al., 1995; Hordijk et al., 1997). In both
RasV12- and RafCAAX-transformed cells, the levels of
Tiam1 protein were strongly reduced or completely absent
(Fig. 3, a and c). Consistent with the effects of MAP kinase
on gene transcription, downregulation of Tiam1 occurred
at the transcriptional level, since Tiam1 mRNA transcripts
were barely detectable in RasV12-transformed cells (Fig. 3
b). We did not find decreased expression of other putative
Rac exchange factors, such as Sos1, PIX, and Vav-2, in
RasV12- or RafCAAX-transformed cells, whereas the
Tiam1 homologue Stef (Hoshino et al., 1999) was not ex-
pressed in MDCK cells (data not shown). However, this
does not exclude that other as yet unidentified exchange
factors for Rac may be downregulated in RasV12- or Raf-
CAAX-transformed cells.
Figure 2. Ras-induced transformation of epithelial MDCK cells
is mediated by the Raf/MAP kinase pathway. a, Phase-contrast
images of wild-type MDCK cells and MDCK cell populations ex-
pressing activated mutants of Ras, Raf kinase, or PI3 kinase. b,
Activation of the Raf/MAP kinase and PI3 kinase pathways in
the different lines was determined by Western blotting of total
cell lysates using antibodies against phospho-MAPK and phos-
pho-PKB/Akt. 
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To substantiate the role of Raf/MAP kinase signaling
in the transcriptional downregulation of Tiam1 and de-
creased Rac activity, we isolated six individual clones from
the RafCAAX-transformed cell population. The mesen-
chymal cell clones 1 and 2, which express relatively high
levels of RafCAAX, displayed high levels of MAP kinase
phosphorylation and loss of Tiam1 expression (Fig. 3 c). In
contrast, the epithelial cell clones 4, 5, and 6, expressed
very low levels of RafCAAX, exhibited control levels of
MAP kinase activation, and expressed normal levels of
Tiam1 (Fig. 3 c). Clone 3 showed an intermediate pheno-
type and moderate levels of MAP kinase activation that
were associated with intermediate levels of Tiam1. The de-
gree of MAP kinase activation in the cell clones thus cor-
related with decreased Tiam1 protein levels and transition
to a mesenchymal phenotype. Similar results were ob-
tained using subclones derived from RasV12-transformed
cells (not shown).
 
It could be argued that Tiam1 downregulation is due to
the phenotypic changes induced by RasV12 or RafCAAX
expression in cells (see Fig. 2), rather than by sustained
Raf/MAP kinase signaling. To exclude this possibility,
we analyzed Tiam1 protein levels in RasV12-transformed
cells that reverted towards an epithelial phenotype upon
introduction of constitutively active RacV12 (Hordijk et
al., 1997). Despite their epithelioid morphology, these
cells still showed a RasV12-mediated increase in MAP ki-
nase activity and failed to restore normal Tiam1 levels
(Fig. 3 a). This strongly suggests that constitutive activa-
tion of the Raf/MAP kinase pathway by oncogenic Ras
causes transcriptional downregulation of Tiam1 expres-
sion, leading to decreased Rac activity and transition to
a mesenchymal phenotype. Treatment of fibroblastoid
RasV12-transformed MDCK cells with the MEK inhibitor
PD98059 (18 h, 20 
 
m
 
M) showed an epithelial-like appear-
ance due to inhibition of polarization and migration of the
cells. However, PD-treated cells hardly formed E-cad-
herin–based adhesions, and no changes in Rac and Rho
activity or Tiam1 were found in response to PD treatment
(not shown). These data do not exclude that, in addition to
the Raf–MAP kinase pathway, other events play a role in
epithelial–mesenchymal transition, such as changes in
phosphorylation of the myosin II light chain or heavy
chain (Klemke et al., 1997; van Leeuwen et al., 1999),
which affect cell spreading and cell contraction, or changes
in phosphorylation of proteins involved in the formation
of E-cadherin adhesions (Kinch et al., 1995).
 
Reconstitution of Rac Activity Is Sufficient to Revert 
Ras or Raf-transformed Cells to an
Epithelial Morphology
 
We next examined whether downregulation of Rac activ-
ity by sustained Raf/MAP kinase signaling could explain
the mesenchymal transition. Reconstitution of Rac activity
to approximately the level of wild-type MDCK cells by ex-
ogenous expression of Tiam1 reverted the fibroblastoid
RafCAAX-expressing cells towards an epithelioid pheno-
type (Fig. 4 a). In these cells, adherens junctions were re-
stored, as illustrated by the relocalization of the marker
proteins E-cadherin (not shown) and 
 
b
 
-catenin (Fig. 4, b–d).
In addition, the tight junction marker ZO-1 was re-
distributed to the sites of cell–cell contact (not shown).
Restoration of Rac activity by Tiam1 in RasV12- and Raf-
CAAX-transformed MDCK cells resulted in strong down-
regulation of Rho activity (Fig. 4 a), a phenomenon that we
also observed in Tiam1- and RacV12-expressing NIH3T3
fibroblasts (Sander et al., 1999). From these data we con-
clude that Rac negatively regulates Rho activity, and that
the lack of this negative regulation in Ras- and Raf-trans-
formed cells is the major cause of increased Rho activity.
Therefore, our data suggest that oncogenic Ras is able to
induce a mesenchymal phenotype in epithelial MDCK
cells by influencing the balance between Rac and Rho ac-
tivity.
 
Discussion
 
As illustrated in Fig. 5, our data indicate complex cross-
talk between Ras, Rac, and Rho in epithelial MDCK cells.
Figure 3. Downregulation of Tiam1 expression by sustained sig-
naling of the Raf/MAP kinase pathway. a, Tiam1 was immuno-
precipitated from wild-type MDCK cells and from cells express-
ing RasV12 alone or RasV12 together with RacV12. MAP kinase
activation was analyzed by phospho-MAPK blotting as described
in Materials and Methods. b, Total RNA isolated from wild-type
MDCK and MDCK cells expressing RasV12 was isolated and
probed for Tiam1 and GAPDH mRNA. c, Six independent cell
clones were selected from the RafCAAX-transduced population
on a phenotypic basis and analyzed for Tiam1 expression and
MAPK activation as described above. Expression of RafCAAX
was determined by Western blotting using a Myc-tag–specific an-
tibody. M, mesenchymal cells; E, epithelial cells; and M/E, inter-
mediate phenotype of the cells. 
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Short-term activation of Ras by HGF/cMet receptor sig-
naling induces a transient, PI3 kinase-dependent Rac acti-
vation, presumably by PI3 kinase-mediated activation or
membrane translocation of exchange factors for Rac, as
shown for Sos, Vav1, and Tiam1 (Han et al., 1998; Nim-
nual et al., 1998; Sander et al., 1998). Of note, Eps8 and
E3b1, two downstream targets of receptor tyrosine ki-
nases, also have been implicated in growth factor-induced
activation of Rac by Ras through regulating the activity of
Sos (Scita et al., 1999). HGF induces a more prolonged ac-
tivation of Rho that occurs independently of PI3 kinase,
indicating that distinct signaling pathways are involved in
HGF-induced activation of Rac and Rho. Stimulation of
NIH3T3 cells with PDGF also results in a transient activa-
tion of Rac. However, in contrast to HGF stimulation of
MDCK cells, Rho is transiently inactivated by PDGF re-
ceptor signaling (Sander et al., 1999). This indicates that
regulation of Rac and Rho activity is dependent on the
growth factor receptor involved, and possibly also on the
cell type studied.
In RasV12-transformed cells, persistent Ras signaling
results in a Raf/MAP kinase-mediated downregulation
of the Rac-specific exchange factor Tiam1, leading to de-
creased Rac activity (Fig. 5). Although the expression of
other putative Rac exchange factors like Sos1, PIX, Vav2,
and Stef was not affected, we cannot exclude that the
expression of as yet unidentified Rac exchange factors is
influenced by oncogenic Ras signaling. Decreased Rac ac-
tivity in RasV12- or RafCAAX-transformed cells is ac-
companied by increased Rho activity, whereas restoration
of Rac activity results in decreased Rho activity in these
cells. This indicates that Rac negatively influences Rho ac-
tivity under conditions where Rho is not activated by sepa-
rate pathways, such as HGF-receptor stimulation. Antago-
nistic roles for Rac and Rho have been demonstrated in
the control of neuronal morphology (Kozma et al., 1997;
van Leeuwen et al., 1997) by regulating myosin light chain
or heavy chain phosphorylation (Sanders et al., 1999; van
Leeuwen et al., 1999). The present data indicate that Rac
can also antagonize Rho in a more direct manner by inhib-
iting Rho at the GTPase level. Previously, we found that
Tiam1-expressing RasV12-transformed MDCK cells showed
a fibroblast-like migratory phenotype when seeded on col-
lagen, but an epithelial phenotype when seeded on fi-
bronectin or laminin (Sander et al., 1998). These pheno-
types were associated with similar levels of Rac activity on
Figure 4. Reconstitution of Rac
activity in RafCAAX-trans-
formed MDCK cells by Tiam1
expression restores their epithe-
lial phenotype and decreases
Rho activity. a, Rac and Rho ac-
tivities in MDCK cells express-
ing RasV12 or RafCAAX alone
or together with Tiam1. b–d,
Immunofluorescent staining of
b-catenin (green) and F-actin
(red) in wild-type MDCK cells
(b), MDCK cells expressing Raf-
CAAX (c), and RafCAAX-
transformed MDCK cells ex-
pressing Tiam1 (d). 
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all substrates, and appeared to be due to a substrate-
induced relocalization of the Tiam1/Rac signaling com-
plex to lamellipodia. The possible formation of different
Rac-dependent signaling complexes escapes detection of
the GTPase pull-down assay, which allows to monitor
overall changes in GTPase activity in cells, but not alter-
ations in localization and/or composition of GTPase com-
plexes.
The observed Rac–Rho antagonism as found in epithe-
lial cells is consistent with our earlier findings in NIH3T3
fibroblasts, where Rac was also shown to downregulate
Rho activity (Sander et al., 1999). High Rac and low Rho
activity is associated with an epithelial-like phenotype in
NIH3T3 fibroblasts, characterized by the formation of
cadherin-based cell–cell adhesions and inhibition of cell
migration. In contrast, elevated levels of Rac and Rho ac-
tivities are associated with a fibroblastoid and migratory
phenotype of these fibroblasts. The present data show that
in epithelial MDCK cells, the balance between Rac and
Rho activity determines the cellular phenotype. Onco-
genic Ras is able to shift this balance by decreasing Rac
and increasing Rho activity, leading to mesenchymal
MDCK cells that have lost the capacity to establish E-cad-
herin–based cell–cell adhesions. It should be noted that the
observed downregulation of Rac activity by RasV12 does
not exclude a requirement for Rac in invasion and migra-
tion of cells. Rather, it appears that the balance between
Rac and Rho activity is a major determinant of epithelial–
mesenchymal transition. Blocking Ras or Rac pathways
using dominant negative mutants inhibits motility (Ridley
et al., 1995; Keely et al., 1997; Shaw et al., 1997), and Rac
activity has been shown to be required for the formation
and maintenance of E-cadherin–based cell–cell adhesions
(Braga et al., 1997; Takaishi et al., 1997; Zhong et al., 1997;
Sander et al., 1998). Both processes appear to be regulated
by Rac-mediated signaling pathways.
How Rac is able to downregulate Rho activity remains a
challenge for future research. The signaling pathway in-
volved lies downstream of Rac and upstream of Rho, since
expression of RacV12 downregulates Rho activity at the
GTPase level. Studies with Rac effector mutants in
NIH3T3 fibroblasts suggest that Rac-mediated signaling
pathways leading to reorganization of the cytoskeleton or
to stimulation of Jun kinase are not involved in downregu-
lation of Rho activity (Sander et al., 1999).
Activated mutants of Rac and Rho have been shown to
cooperate with Ras in the transformation of fibroblasts
(Qiu et al., 1995a,b; Khosravi-Far et al., 1995). Here, we
show that in epithelial MDCK cells, RasV12-induced mor-
phological transformation involves downregulation of Rac
and upregulation of Rho activity. In addition to a role in
cytoskeletal reorganization, the observed increase in Rho
activity may also contribute to uncontrolled growth by
suppressing Ras-mediated induction of the cyclin-depen-
dent kinase inhibitor p21
 
Waf1/Cip1
 
, thereby allowing cell cy-
cle progression (Olson et al., 1998).
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